Trials / Completed
CompletedNCT00754000
The AIM Study: Assessing the Impact of Margin Reduction
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 82 (actual)
- Sponsor
- Varian, a Siemens Healthineers Company · Industry
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will observe patients who receive external beam radiation for prostate cancer. These patients will be localized and tracked (targeted) with the Calypso 4D Localization System. These patients will have a uniform treatment plan with reduced PTVs (prostate treatment volume) and will be assessed at multiple time points for quality of life and side effects related to radiation therapy.
Detailed description
EPIC surveys and adverse events recorded and categorized using the CTCAE v3.0 will be collected and summary statistics performed. The patient's individual tracking graphs will be evaluated for motion type and frequency.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Observation | AE monitoring and EPIC QOL survey |
Timeline
- Start date
- 2008-07-01
- Completion
- 2009-09-01
- First posted
- 2008-09-17
- Last updated
- 2012-04-30
Locations
4 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00754000. Inclusion in this directory is not an endorsement.